Cam Garner


Cam Garner is a pharmaceutical executive with over 40 years of diverse experience in the healthcare industry ranging from diagnostics and devices to pharmaceuticals. He was part of the senior management team that built Hybritech, Inc. After facilitating the acquisition of Dura Pharmaceuticals, in 1989 for $5 million, Garner served as chief executive officer and chairman until the company was sold in November 2000 for $1.8 billion to Elan Corporation. During his tenure at Dura, annual revenues grew from $2 million to more than $300 million. In addition to Zavante, Garner has founded and co-founded numerous specialty pharmaceutical companies in San Diego including Alastin Skincare, Cadence Pharmaceuticals, DJ Pharma, Elevation Pharmaceuticals, Evoke Pharma, Kalyra Pharmaceuticals, Meritage Pharma, Neurelis, OrPro Therapeutics, SkinMedica, Somaxon Pharmaceuticals, Tokalas, Verus Pharmaceuticals, Xcel Pharmaceuticals and Zogenix. Garner currently also serves as chairman of Evoke, Kalyra, OrPro and Zogenix. He is also chairman-elect and serves on the executive committee of UCSD Moores Cancer Center in San Diego. Garner earned his bachelor’s degree in biology from Virginia Wesleyan College and a master’s in business from Baldwin-Wallace College.